Elligo expands research network with oncology center partnership

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/LewisTsePuiLung)
(Image: Getty/LewisTsePuiLung)

Related tags: Elligo Health Research, Clinical research, Research, Clinical trial, Partnership, Breast cancer, Oncology

Elligo expands its Research Ready network and adds its first oncology practice through a partnership with Austin Cancer Center, which is currently enrolling patients for breast cancer studies.

The health research organization, Elligo, will work with the Austin Cancer Center (ACC) to add its clinical research network,while ACC’s oncologists will offer research as a care option.

Mary Costello, VP of clinic development and patient advocacy at Elligo told us, “Most research starts at academic medical centers and standalone research dedicated practices. By partnering with health care providers in the community, Elligo helps extend access and expand the reach of the study itself.”

According to ACC, the partnership enables its patients to remain under its care while receiving opportunities to participate in clinical studies through Elligo’s Research Ready network. The network operates on its Goes Direct approach connecting patients and sites to research studies across the industry.

Costello said Elligo selected to work with physicians in Austin, TX, the 11th​ largest city in the US, “to allow cancer patients the opportunity to access clinical research in their own community, which increases the likelihood they will participate and extends the chance to participate to all patients, not just those fortunate enough to be able to travel outside of their community.”

ACC currently offers clinical care across medical oncology, comprehensive breast care and breast oncology, gynecologic oncology, radiation oncology, neuro-oncology, and diagnostic and interventional radiology specialties.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars